Development of Novel M1 Antagonist Scaffolds Through the Continued Optimization of the MLPCN Probe ML012

Bioorganic and Medicinal Chemistry Letters - United Kingdom
doi 10.1016/j.bmcl.2012.06.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Further Optimization of the M5 NAM MLPCN Probe ML375: Tactics and Challenges

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2015English

Integration of Text Mining and Binary QSAR Models for Novel Anti-Hypertensive Antagonist Scaffolds

Biophysical Journal
Biophysics
2019English

Potency Enhancement of the Κ-Opioid Receptor Antagonist Probe ML140 Through Sulfonamide Constraint Utilizing a Tetrahydroisoquinoline Motif

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2015English

Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

The Utilization of Spirocyclic Scaffolds in Novel Drug Discovery

Expert Opinion on Drug Discovery
Drug Discovery
2016English

Development of the Scanning Atom Probe

Microscopy and Microanalysis
Instrumentation
2003English

M1 Muscarinic Receptor for the Development of Auditory Cortical Function

Molecular Brain
Molecular NeuroscienceMolecular BiologyCellular
2010English

Self Presentation of Communist Albania Through the Antagonist Discourse

European Journal of Interdisciplinary Studies
2016English

Recent Development in Thrombin Receptor Antagonist as Novel Antithrombotic Agent

Open Journal of Medicinal Chemistry
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy